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Abstract
The neonatal Fc receptor (FcRn) regulates IgG and albumin homeostasis, mediates maternal IgG transport, takes an active
role in phagocytosis, and delivers antigen for presentation. We have previously shown that overexpression of FcRn in
transgenic mice significantly improves the humoral immune response. Because rabbits are an important source of
polyclonal and monoclonal antibodies, adaptation of our FcRn overexpression technology in this species would bring
significant advantages. We cloned the full length cDNA of the rabbit FcRn alpha-chain and found that it is similar to its
orthologous analyzed so far. The rabbit FcRn - IgG contact residues are highly conserved, and based on this we predicted
pH dependent interaction, which we confirmed by analyzing the pH dependent binding of FcRn to rabbit IgG using yolk sac
lysates of rabbit fetuses by Western blot. Using immunohistochemistry, we detected strong FcRn staining in the
endodermal cells of the rabbit yolk sac membrane, while the placental trophoblast cells and amnion showed no FcRn
staining. Then, using BAC transgenesis we generated transgenic rabbits carrying and overexpressing a 110 kb rabbit
genomic fragment encoding the FcRn. These transgenic rabbits – having one extra copy of the FcRn when hemizygous and
two extra copies when homozygous - showed improved IgG protection and an augmented humoral immune response
when immunized with a variety of different antigens. Our results in these transgenic rabbits demonstrate an increased
immune response, similar to what we described in mice, indicating that FcRn overexpression brings significant advantages
for the production of polyclonal and monoclonal antibodies.
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Introduction
Maintenance of antibody (Ab) levels requires continuous
secretion of immunoglobulin (Ig) by plasma cells and protection
from degradation.IgG isa classofAbsthat isuniquetomammals.It
is the most abundant Ab in serum and is also passively transferred
to mammalian offspring. From the standpoint of therapeutic,
diagnostic or research Ab reagent production, it is the most
important Ab class worth serious consideration when preparing an
Ab reagent.
In 1958, Brambell described a saturable receptor that mediates
the transport of maternal gamma-globulin to the fetus [1]; he then
inferred the presenceof a similar oridentical receptorthat protected
gamma-globulin from catabolism to make it the longest surviving of
allplasmaproteins[2]. Atabout the same time,itwas shownthat 7S
c-globulin (IgG) is the fraction of Ig that was protected by such a
mechanism [3]; a few years later, it was also shown that IgG
mediates maternal immune transport in mammals [4,5].
The neonatal Fc receptor (FcRn) was first identified in the 1970s
as the protein that mediates transfer of maternal, milk-borne IgGs
across the rodent neonatal intestine [6]. Subsequently, FcRn was
shown to be a heterodimer of two polypeptides that binds IgG at
the CH2–CH3 interface, in a strictly pH dependent way with
binding occurring at slightly acidic pH and no detectable binding
at pH 7.4 [7,8]. It was finally characterized as composed of an
MHC class-I like a-chain and beta 2-microglobulin (b2m) [9].
FcRn has proven to be a key player in regulating the transport of
IgG within and across cells of diverse origin and it also serves to
rescue IgG and albumin from degradation, thereby prolonging
their half-lives [10]. IgG protection was originally thought to be
mediated by capillary endothelial cells [11]; however, recent
findings suggest that this process also occurs in hematopoietic cells
[12,13], or even in mammary epithelial cells during lactation [14].
FcRn orthologous have been isolated from mouse, rat, human,
sheep, cow, possum, pig and camel, suggesting that this receptor is
present in essentially all mammalian species [10]. More recently,
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antigen-IgG immune-complex phagocytosis by neutrophils [15],
and also in antigen presentation of IgG immune complexes by
professional antigen presenting cells [16,17,18,19].
The existence of the Brambell receptor was also hypothesized in
rabbits when early data showed receptor mediated maternal gamma-
globulin transport through rabbit yolk sac [20] where the receptor was
localized to the glycocalyx-coated ve s i c l e sa sw e l la st h eg l y c o c a l y x -
coated brush border [21], and that increased serum gamma-globulin
resulted in faster catabolism in this species [22]. It was also shown that
the rabbit IgG half-life depends on the Fc fragment [3], and the
maternal IgG transport through yolk sac is CH2 domain dependent
[23]. Another study indicated that the mouse and rabbit IgGs, pre-
incubated with staphylococcalprotein A(SpA), had muchshorterhalf-
lives [24] and thus suggested that those amino acid residues that are
involved in IgG protection or maternal transport locate in the CH2–
CH3 domain interface. The overlapping residues at the CH2–CH3
domain interface with the FcRn and SpA binding sites were
confirmed a decade later [25]. Despite the fact that rabbit served as
an important model in studying maternal immunoglobulin transport
and IgG catabolism from the beginning, the FcRn receptor and its
function has not been characterized in this species.
We, and others, have shown that higher than normal expression
levels of FcRn reduced exogenous IgG catabolism in transgenic
mice, resulting in higher circulating levels of IgG [14,26,27]. Our
morerecent studies havedemonstrated that FcRn overexpression in
transgenic (Tg) mice enhances the expansion and diversity of
antigen-specific B cells and plasma cells in secondary lymphoid
organs [28]. Furthermore, we found that these Tg micewere able to
mount robust humoral response against weakly immunogenic
antigens and to improve hybridoma production efficiency without
any sign of autoimmunity [29,30,31]. Since rabbit is one of the most
important sources of polyclonal, and recently also monoclonal, Abs
for therapeutic, diagnostic and research applications, adaptation of
the FcRn overexpression technology in this species would bring
significant advantages. Consequently, we decided to clone and
characterizethe rabbitFcRn, createTg rabbits that overexpressthis
receptor, and analyze their humoral immune response.
Results
1. Characterization of the rabbit FcRn a-chain cDNA
To isolate the full length of the rabbit FcRn a-chain, we first
synthesized cDNA from the RNA isolated from rabbit liver and
spleen. We then performed 39-RACE and 59-RACE, using rabbit
specific primers which were designed based on available EST
sequence data. The obtained composite DNA sequence of 1415 bp
contained a segment of the 59-untranslated (UT) region, the a1, a2,
a3 domains, the transmembrane (TM) domain, the cytoplasmic
(CYT) domain and ended with the 39-UT region of the rabbit cDNA.
(The sequence data have been submitted to the NCBI Nucleotide
Sequence Databases under the accession number: JN558833). The
data were compared to other published FcRn a-chain sequences, and
showed a99%homology (withthree mismatches)to a rabbit FcRn a-
chain cDNA that was deposited in GenBank (NM_001122937.1)
albeitwithout functionalcharacterizationand publication. The rabbit
FcRn a-chain specific cDNA sequence we obtained showed high
homology to its orthologous analyzed thus far.
2. Rabbit FcRn a-chain mRNA is expressed in all analyzed
tissues and cells; the rabbit embryos start to express
FcRn by 6 dpc, close to implantation time
Subsequently, we examined the tissue distribution of rabbit
FcRn a-chain using PCR. We could detect expected FcRn specific
amplicons from all tissues and cells we analyzed including kidney,
ovary, uterus, salivary gland, lymph node, lung, brain, liver,
spleen, small intestine, placenta, amnion and yolk sac, rabbit
blastocyst and embryo as well as peritoneal macrophages (data not
shown). We have also investigated the expression of the rabbit
FcRn a-chain in rabbit blastocysts and embryos in different time
points (3.5; 4.5; 6; 9 and 13.5 dpc) by PCR. We found that rabbit
embryos start to express FcRn by 6 dpc, close to the implantation
time (Fig. 1). There is some similarity in the expression of FcRn in
rabbit and mouse because this expression occurs before implan-
tation in both species, but there is also differences because rabbit
expresses the gene in the late preimplantation stages only, as
mouse expresses it in all preimplantation stages tested [32].
3. Characterization of the deduced amino acid sequence
of the rabbit FcRn a-chain
The full-length transcript of the rabbit FcRn a-chain we isolated
is composed of three extracellular domains (a1-a2-a3), a
transmembrane (TM) region and a cytoplasmic (CYT) tail; the
molecular weight of the matured rabbit FcRn a-chain protein is
estimated to be 38 kDa (without carbohydrate side chain) based on
its amino acid sequence. Similarly to the cDNA sequence
comparison, the rabbit FcRn a-chain amino acid sequence shows
99% similarity to the rabbit FcRn deposited earlier in GenBank
(NM_001122937.1) with two substitutes. The first one is in the a3-
domain; Ser189 in our rabbit FcRn sequence (similarly to its
human and bovine orthologous) while NM_001122937.1 sequence
contains a Pro189 in this position. The other one is in the
transmembrane domain; Pro294 in our rabbit FcRn sequence
while NM_001122937.1 sequence contains an Ala294 in this
position (similarly to its human and bovine orthologous). No
functional features have been allocated to these regions thus far.
The rabbit FcRn a-chain amino acid sequence also shows high
similarity (70–75%) to the coding region of the human, swine,
canine, dromedary, bovine, ovine; a moderate homology (63%) to
rat and mouse; and a low homology (46%) to possum FcRn
sequences querying the Reference protein database with Blastp
(NCBI).
A comparison between rat, mouse, human and bovine FcRn a-
chain and b2m residues which are supposed to be involved in
binding to IgG molecules have been extensively analyzed based on
a crystallography analysis of a rat FcRn-heterodimeric Fc complex
[33]. This study compared important residues in the interaction
and found that the rat Glu117, Glu118, Glu132, Trp133, Glu135
and Asp137 (aa numbering follows the rat sequence) are highly
conserved in mouse, human and bovine and their mutations result
Figure 1. Rabbit embryos start to express FcRn by 6 dpc, close
to the implantation time. Rabbit FcRn a-chain expression was
analysed in rabbit blastocysts and embryos at different time points by
PCR. L-ladder, 1–3.5 dpc rabbit blastocyst, 2–4.5 dpc rabbit blastocyst,
3–6 dpc rabbit embryo, 4–9 dpc rabbit embryo, 5–13.5 dpc rabbit
embryo, 6 - negative control (DNA omitted).
doi:10.1371/journal.pone.0028869.g001
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a-chain sequences to its rat [9], human [34], bovine [35]
orthologous in Fig. 2, we found that among the indicated ones,
Glu118 is replaced by Asp118 (conservative substitution) in rabbit
while Glu132 is replaced by Asp132 (conservative substitution) in
human and bovine. Although, Asp137 (acidic) was proven as
important in rat FcRn/IgG interaction, it is not conserved, as the
human, orangutan, macaque, rabbit and possum FcRn sequences
have Leu (neutral) and the bovine, ovine, swine and dromedary
FcRn sequences have Arg (basic) at this position [36]. The rat FcRn
Asp137 interacts with His436 of IgG, however, His436 is not
conserved in all Fcc chains and it is possible that human FcRn
Leu137 weakly interacts with Tyr436 of human IgG [37]. As rabbit
FcRn has Leu137 and rabbit IgG contains Tyr436, these residues
are also potentially involved in the interaction of rabbitFcRn – IgG.
The other key residues in IgG that are in contact with FcRn, the
Gly191, Ile253, His310 and His435 [33,38] are highly conserved
across species including the rabbit.
FcRn is composed of the FcRn a-chain and the b2m, and the
first amino acid of the b2m is also in contact with IgG [33]. In
most of the species analyzed so far this is Ile1, and rabbit has a
conservative substitution Val1 in this position [39]. The conserved
amino acid residues that are involved in FcRn – IgG interaction in
rabbit indicate that the two pH-dependent salt bridges involving
amino acid residues His310 and His435 of the IgG/Fc would still
form at pH 6.0.
FcRn binds not only IgG, but also albumin and the contact
residue for this binding in the FcRn is His166 [40] which is
conserved and present in all FcRn a-chain sequences thus far
characterized, including the rabbit, suggesting that the rabbit
FcRn also binds albumin.
The cytosolic tail motifs of rat FcRn that regulate endocytosis
and basolateral targeting have been identified by analyses of
mutated FcRn variants in transfected IMCD cells [41,42,43]. Both
tryptophan (W311; with tryptophan replacing the more common
tyrosine in the YXXtheta motif) and dileucine (Leu322Leu323)
motifs have been shown to play partially redundant roles in
endocytosis [41]. The tryptophan and dileucine motifs are
conserved across species, including rabbit, suggesting that
additional differences such as variations in glycosylation patterns
account for cross-species variability in trafficking [44]. There are
potential N-linked glycosylation sites (N-X-S or N-X-T; where X is
any amino acid except proline) at positions 87 (present in mouse
and rat sequences), 104 (present in all FcRn species, including
rabbit), 128 (present in mouse and rat sequences), and 225 (present
in rat and mouse FcRn sequences).
It is worth to note that some species (e.g., possum, cows, sheep,
dromedaries, pigs, and dogs) have cytosolic tails that are 10
residues shorter than those of other species (e.g., humans,
macaques, orangutans, rats, and mice). Although, the C-terminal
of the cytoplasmic domain of the rabbit FcRn is similar to its
human or rat orthologous, there is a five amino acid deletion in
Figure 2. Domain-by-domain alignment of the predicted amino acid sequences for rabbit, human, bovine, rat FcRn a-chain
sequences. Structural and functional features are highlighted, potential N-linked glycosylation sites (N-X-S or N-X-T, where X is any amino acid
except proline) at positions 87, 128, 225 (present in rat FcRn [9]) and 104 (present in all FcRn species) are indicated by empty and filled triangles to
denote non-conserved and conserved sites, respectively. Numbering is based on the rat FcRn sequence. Residues at the interface between rat FcRn
and Fc based on a crystallography analysis of a rat FcRn-heterodimeric Fc complex [33] are labelled with asterisks. Conserved His at position 166 is
considered to bind to albumin [40] and is indicated by a plus sign. FcRn has been shown to have two endocytosis signals, a tryptophan based motif
(W311) and a dileucine motif (L322 and L323) indicated by # characters) [41]. Consensus residues are assigned based on the number of occurrences
of the character in the column, emphasizing the degree of conservation. The higher the conservation in a column the darker the background of the
character [68].
doi:10.1371/journal.pone.0028869.g002
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to this deleted region.
Searches of the NCBI and Ensembl databases resulted in finding
several FcRn orthologs (beyond the well characterized FcRn
sequences) which suggested that the sequences of their cytoplasmic
domains most likely reflect the phylogenetic position of these species
[45] (Fig. 3). Marsupials (possum, opossum, and wallaby) have
relatively short cytoplasmic domains that composedof 27–28 amino
acid residues. Early mammalian phylogeny resulted in clades
Atlantogenata and Boreoeutheria. The only (predicted) sequence
we found belonging to Atlantogenata (elephant) shows a 7–8 amino
acid longer cytoplasmic domain as compared to Marsupials.
Boreoeutheria is composed of the sister taxa Laurasiatheria and
Euarchontoglires. Species belong to Euarchontoglires analyzed so
far (human, chimp, orangutan, gibbon, macaques, marmoset,
lemur, rabbit, pika, squirrel, hamster, rat and mouse) preserved the
extra amino acids of the FcRn C-terminal with the exception of the
guinea pig (based on its predicted amino acid sequence). Rabbit lost
five amino acids in a more N-terminal (or middle) part of the
cytoplasmic domain. As pika (Ochotona), another Lagomorphs,
possesses these residues, the five amino acid deletion is thus specific
of either rabbit or Leporidae family.
Animals belong to the Laurasiatheria clade (bovine, sheep, pig,
horse, bat, dog and panda) lost 10 amino acids of their FcRn C-
Figure 3. Cytoplasmic domains of the FcRn sequences most likely reflect their phylogenetic position. Marsupials (possum, opossum,
and wallaby) have relatively short cytoplasmic domains composed of 27–28 amino acid residues. The next phylogenetic step resulted in clades
Atlantogenata and Boreoeutheria. The only (predicted) sequence we found belonging to Atlantogenata (elephant) shows a 7–8 amino acid longer
cytoplasmic domain as compared to Marsupials. Boreoeutheria is composed of the sister taxa Laurasiatheria and Euarchontoglires. Species belong to
Euarchontoglires analyzed so far (human, chimp, gorilla, orangutan, gibbon, rhesus, marmoset, lemur, rabbit, pika, squirrel, hamster, rat and mouse)
preserved these extra amino acids of the FcRn C-terminal with the exception of the guinea pig (based on its predicted amino acid sequence). Rabbit
lost five amino acids in a more N-terminal (or middle) part of the cytoplasmic domain. As pika (Ochotona), another Lagomorphs, possesses these
residues, the five amino acid deletion is thus specific of either rabbit or Leporidae family. Animals belong to the Laurasiatheria clade (bovine, sheep,
pig, horse, bat, dog and panda) lost 10 amino acids of their FcRn C-terminals. Phylogenetic tree was created based on Prasad et al. [45] where some
branch lengths were optimized for clarity and space.
doi:10.1371/journal.pone.0028869.g003
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sequence and found that the reason of this shorter cytoplasmic
domain is a single mutation in the reading frame of the bovine
FcRn that resulted in a stop codon. Nucleotides which follow this
stop signal represent codons for similar amino acid residues which
are found at the 39-end of the human, rat and mouse molecules
[35]. Analyzing the coding sequence of other species in this group
shows similar pattern (data not shown).
4. Chicken polyclonal antibody raised against the bovine
FcRn a-chain cross-reacts with rabbit FcRn a-chain
In order to analyze the rabbit FcRn localization in different
tissues and characterize its pH dependent IgG binding, we first
tested a polyclonal chicken antibody that was raised against a
recombinant, soluble bovine FcRn, if it cross-reacts with the rabbit
FcRn in Western blot. Fig. 4 shows that the chicken antibody
strongly and specifically reacted with the soluble recombinant
bovine FcRn which was used for immunization (its estimated
molecular weight is 30 kDa), a ,40-kDa band that is consistent
with the known molecular weight of the bovine FcRn a-chain in
the protein extract from a bovine FcRn stably transfected cell line
(B4) [46] which strongly expresses the functional form of the
bovine FcRn and a ,40-kDa band that is consistent with the
calculated molecular weight of the rabbit FcRn a-chain in the
protein extract from the rabbit yolk sac. Thus, we concluded that
the chicken polyclonal antibody that was raised against the bovine
FcRn cross-reacts with the rabbit FcRn a-chain.
5. Immunohistochemical detection of the rabbit FcRn a-
chain in rabbit yolk sac, amnion and placenta
Previous investigations in the rabbit demonstrated that the
transfer of IgG (and a lower extent albumin) occurs across the fetal
yolk sac membrane (YSM) from the maternal uterine lumen to the
fetus [47]. Since we have successfully detected rabbit FcRn in the
rabbit yolk sac (while studying the pH dependent rabbit FcRn IgG
interaction), we decided to study the cellular distribution of this
receptor in the rabbit yolk sac membrane. FcRn expression was
evaluated in tissue sections from YSM, amnion and placenta from
23 dpc fetuses. We have selected this time point from previous
data which indicated that the rate of transmission of rabbit IgG
injected into the uterine cavity increases nearly linearly from a low
level at 20 dpc to a maximum at 26 dpc and declines thereafter
[47]. For immunohistochemical staining we used the chicken
FcRn a-chain specific antibody we generated against the bovine
FcRn and validated to be bovine and rabbit FcRn a-chain specific
in Western blot. In parallel, we also used a commercially available
goat polyclonal mouse FcRn a-chain specific antibody that cross-
reacts with rat, human and bovine FcRn (based on product
information). We detected strong FcRn staining in the apical
plasma membrane of the brush border’s endodermal cells, in the
apical region and in vesicles that transverse the endoderm cells of
the rabbit YSM with both FcRn specific antibodies (Fig. 5 YSM/
g and YSM/ch). The vascular mesenchyme (VM) was not FcRn
positive; although the chicken antibody reacted with the
endothelial cells of the vitelline vessels (VV) the goat antibody
only weakly stained in these cells (Fig. 5 YSM/g). These staining
show very similar pattern to those previous studies when absorbed
IgG was detected in this tissue [21,48,49]. In the placenta, only
capillary endothelial cells were FcRn a-chain positive; the
trophoblast cells showed no FcRn staining (Fig. 5 P). We could
not detect FcRn expression in the amnion (Fig. 5 A). These
findings correlate with previous studies and thus we could confirm
that the antibodies we used stained the rabbit FcRn in the YSM
and also in the placental capillary endothelial cells.
6. pH dependent binding of the rabbit FcRn to IgG
The sequence data of the rabbit FcRn and IgG suggests that
their interaction is potentially pH dependent as is the case in all
species thus far analyzed [10]. To confirm this hypothesis we
analyzed this interaction in a pH dependent IgG-binding assay
that was described earlier [50]. In this assay we extracted protein
from yolk sac of 24 dpc rabbit fetuses and analyzed its pH
dependent binding at pH 6.0 and pH 7.4 to rabbit IgG that was
coupled to a Sepharose matrix. Absorbed proteins were then
eluted from the matrix and the presence of the FcRn was Western
blot tested in these samples as well as in the unbound fractions.
Fig. 6 shows that the eluted samples contain FcRn only if binding
occurred at pH 6.0 but not at pH 7.4 (bands 5 and 6, respectively).
Confirming this result, we could not detect FcRn in the unbound
fraction when binding occurred at pH 6.0 (i.e. all FcRn molecule
bound to matrix) but there was detectable FcRn when pH 7.4
buffer was used (i.e. at this pH no FcRn bound to the IgG-matrix)
(bands 3 and 4, respectively). Recombinant bovine FcRn [46] and
rabbit yolk sac protein extract were used as positive controls (bands
1 and 2, respectively). This study showed that similar to all of its
orthologous analyzed so far, the rabbit FcRn interacted with
rabbit IgG at pH 6.0, but not at pH 7.4.
7. BAC transgenic rabbits carrying and overexpressing
extra copies of rabbit FcRn
262E02, a rabbit BAC clone containing the FcRn a-chain
coding sequence (FCGRT) located on a 110 kb genomic insert
was identified using PCR screening method. Both in human and
mouse, the genes are in the same order on the chromosome
(synteny): RPL13A, FCGRT, reticulocalbin 3, NOSIP and prolin
rich Gla2-like (PRRG2). In OryCun2.0 assembly (Ensembl),
RPL13A, FCGRT, reticulocalbin 3 and NOSIP are on the same
contig in this order, PRRG2 is also on this contig outside NOSIP
but non-annotated. The presence of the ribosomal protein L13a-
like, reticulocalbin 3, prolin rich Gla 2-like genes were also
identified by PCR on this BAC clone (data not shown). These
PCR results and the data we generated with the transgenic rabbits
carrying this BAC clone, including extra copies of the integrated
Figure 4. Detection of the rabbit FcRn in Western blot. This
Western blot shows that the chicken antibody strongly and specifically
reacted with the soluble recombinant bovine FcRn which was used for
immunization (its estimated molecular weight is 30 kDa), a ,40-kDa
band that is consistent with the known molecular weight of the bovine
FcRn a-chain in the protein extract from a bovine FcRn stably
transfected cell line (B4) [46] which strongly expresses the functional
form of the bovine FcRn and a ,40-kDa band that is consistent with the
calculated molecular weight of the rabbit FcRn a-chain in the protein
extract from the rabbit yolk sac from 24 dpc fetuses.
doi:10.1371/journal.pone.0028869.g004
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and different immunophenotype suggest that the FCGRT gene is
fully intact and localized in the internal part of this BAC clone.
To investigate the potential of the FcRn overexpression in
transgenic rabbits, the linearized BAC clone harboring the rabbit
FCGRT gene and its regulatory region was microinjected into
fertilized rabbit zygotes. 1724 injected embryos were transferred
into 95 pseudopregnant females. Altogether 125 rabbits were born
from 29 does. Transfer and transgenic efficiencies were lower in
comparison to our earlier transgenic rabbit experiments [51,52],
which we hypothesize to be caused by the relatively large size of
the transgene. Five transgenic founders were identified by BAC
backbone specific PCR primers, one of which was stillborn. Three
transgenic lines were originally established carrying the transgene.
We selected one transgenic line - #78 - to further characterize its
immunophenotype.
BAC copy number was determined by absolute quantification of
the transgene by real time PCR and found that one and two extra
copies of the transgene had been integrated in hemizygous and
homozygous Tg rabbits, respectively (Fig. 7A). We also detected
the integrated extra copies of the rabbit FcRn gene in homozygous
Tg rabbits by quantitative genomic PCR (Fig. 7B).
To distinguish between the rabbit FcRn endogene and
transgene expression, a quantitative real time RT-PCR assay
was established. Rabbit FcRn levels were normalized to rabbit
beta-actin. RNA was isolated and pooled from the leukocytes of 5-
5-4 homozygous, hemizygous and control animals, respectively.
Figure 5. FcRn expression was evaluated in tissue sections from rabbit yolk sac, amnion and placenta from 23 dpc fetuses. For
immunohistochemical staining we used a commercially available goat polyclonal mouse FcRn a-chain specific antibody (/g) which cross-reacts with
rat, human and bovine FcRn. In the yolk sac membrane (YSM), we also used the chicken FcRn a-chain specific antibody (/ch) which we generated and
validated to be rabbit FcRn a-chain specific. We detected strong FcRn specific staining in the apical plasma membrane of the brush border, in the
apical region and in vesicles that transverse the endoderm cells (YSE), in the endothelial cells of the vitelline vessels (VV), but not in the vascular
mesenchyme (VM) of the rabbit YSM, with the goat and chicken FcRn specific antibodies (YSM/g and YSM/ch, respectively). In the placenta (P),
capillary endothelial cells were FcRn a-chain positive, while the trophoblast cells (asterisk) showed no FcRn reactivity. We could not detect the FcRn in
the amnion (A). (YSM/g-; YSM/ch- and P- represents controls without FcRn a-chain specific antibody; scale bar=25 mm.)
doi:10.1371/journal.pone.0028869.g005
Figure 6. Detection of pH-dependent FcRn binding of IgG in
rabbit yolk sac samples. In this assay we analyzed the pH dependent
binding of the lysate of rabbit yolk sac of 24 days post coitum (dpc)
embryos at pH 6.0 and pH 7.4 to rabbit IgG that was coupled to a
Sepharose matrix. Absorbed proteins were then eluated from the matrix
and the presence of the FcRn was Western blot tested in these samples
as well as in the unbound fractions. The eluted samples contain FcRn
only if binding occurred at pH 6 but not at pH 7.4 (bands 5 and 6,
respectively). Confirming this result, we could not detect FcRn in the
unbound fraction when binding occurred at pH 6.0 (i.e. all FcRn
molecule bound to matrix) but FcRn remained in the unbound fraction
when the pH of reaction media was neutral (i.e. at this pH no FcRn
bound to the IgG-matrix) (bands 3 and 4, respectively). Recombinant
bovine FcRn [46] and rabbit yolk sac protein extract were used as
positive controls (bands 1 and 2, respectively).
doi:10.1371/journal.pone.0028869.g006
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animals, as it showed 1.83-fold and 2.49-fold higher expression of
the rabbit FcRn mRNA in hemizygous and homozygous animals,
respectively, than those of the wild-type rabbits (Fig. 7C).
In conclusion, our data show that the integrated transgene is
expressed as the rabbit FcRn a-chain mRNA level is higher in
both the hemizygous and homozygous rabbits as compared to
their wt controls. In addition there is a difference between the
hemizygous and heterozygous animals.
8. Increased serum persistence of the rabbit IgG in
transgenic rabbits
Pharmacokinetic studies in mice overexpressing FcRn showed
that the efficiency of IgG protection was higher [14,27,53]. In order
to analyze if FcRn overexpression results in a similar reduction of
IgG catabolism in rabbits, we analyzed the pharmacokinetic
behavior of rabbit IgG in Tg (+/+) animals that carry two extra
copies of the rabbit FcRn and compared these results with wt
rabbits. The clearance curves of the measured OVA-specific IgG
were biphasic, with phase 1 (alpha phase) representing equilibration
between the intravascular and extravascular compartments, and
phase 2 (beta-phase) representing a slow elimination. We analyzed
the beta phase half-lives of rabbit IgG from day 2 to 13, and found
that the Tg rabbits demonstrated increased serum persistence of
rabbit IgG because the beta phase half-lives were 7.160.46 days
(mean 6 SEM) as compared to their controls which showed
5.360.3 days (Fig. 8A, 8B). The difference of the beta-phase half-
life may be even greater as Tg animals have higher total IgG level
(Fig. 8C, Fig. 9B) as compared to the controls, which increases the
fractional catabolic rate. As a result, we concluded that the
transgenic FcRn was functionally expressed and elongated the
half-life of rabbit IgG in these animals.
9. Augmented humoral immune response in transgenic
rabbits
To investigate the consequences on the humoral immune
response in transgenic rabbits that overexpress FcRn, we first
immunized these animals (Tg +/2 carrying one extra copy) with
OVA. No difference between Tg and wt animals was observed
during the primary immune response; however, after the booster
immunization, the OVA-specific IgG titers were nearly doubled in
Tg rabbits as compared with the wt animals and this difference
was significant (P,0.05) (Fig. 9A). We found that the total IgG
level rose steadily after immunization and reached peak levels on
day 49 in both Tg and wt animals. Notably, we found a
remarkable and significant difference at the highest IgG levels,
which were 31.6162.7 mg/ml in Tg rabbits versus 14.862.6 mg/
ml (mean 6 SEM) in wt (P,0.01) (Fig. 9B).
Following this experiment, we analyzed a hapten-specific
immune response by immunizing Tg (+/2) and wt rabbits with
TNP-BSA. The TNP-specific IgG levels were modestly higher in
Tg rabbits (with the exception of one Tg animal that showed
double TNP-specific IgG) as compared to their wt controls at the
peak of the immune response, on day 49, which was one week
after the second booster immunization (Fig. 9C). The total IgG
level was also significantly (P,0.01) elevated in the Tg animals
compared to their controls (Fig. 9D).
Finally, the same rabbits that had been immunized by TNP-
BSA were immunized with a conserved influenza hemagglutinin
epitope (HA2; which is considered as a weakly immunogenic
antigen) conjugated to KLH. (We used these rabbits due to the
limitation in the number of Tg animals.) The mean of the HA2-
specific IgG levels was double (P,0.01) at the peak of the immune
response, on day 56, which was two weeks after the second booster
immunization, with an almost doubled level of total IgG as
compared to their wt controls (Fig. 9E, 9F).
In conclusion, Tg rabbits that overexpress rabbit FcRn show
augmented humoral immune response, similarly to the result
shown by those Tg mice that overexpress bovine FcRn [28,29,52].
Discussion
Immunization protocols for the production and subsequent
maintenance of high levels of antigen-specific polyclonal antibody
require hyperimmunization. Although serum IgG levels may
Figure 7. Quantitative real time PCR analysis of transgenic rabbit line #78. We determined the copy number of the transgene integrated
into the genome and its expression levels by real time PCR. A. Quantitative PCR standard curve and equation to determine the exact copy number of
the transgene. According to the linear regression calculation, the 23.31 Ct value that represents the hemizygous line #78 (TG +/2) results in 0.97
which corresponds a single copy integration event (Q represents copy number). B. We also detected the integrated extra copies of the rabbit FcRn
gene in homozygous Tg rabbits by quantitative genomic PCR. C. Relative rabbit FcRn expression levels in hemizygous and homozygous transgenic
line #78 shows expression of the transgene in leukocytes of the animals tested. Values shown are the mean 6 SEM. TG (+/2)- transgenic
hemizygous, TG (+/+)- transgenic homozygous, WT- control animals.
doi:10.1371/journal.pone.0028869.g007
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breakdown is also exponentially increased [2,22]. Therefore,
frequent immunizations are required to maintain high levels of Ag-
specific IgG. FcRn is known to be involved in transporting IgGs
within and across the cells of diverse origin, and in doing so, they
regulate IgG and albumin concentrations and transport through-
out the body [54]. More recently, several publications have shown
that FcRn plays major roles in Ag-IgG immune-complex
phagocytosis by neutrophils [15], in antigen presentation of IgG
immune complexes by professional antigen presenting cells
[16,17,18,19] and in generating antigen specific antibodies [18].
We, and others, have shown that higher than normal expression
levels of FcRn reduced exogenous IgG catabolism in Tg mice,
resulting in higher circulating levels of IgG [14,26,27]. Our more
recent studies have demonstrated that FcRn overexpression in Tg
mice greatly augment humoral immune response [28,29,55].
The first step of our study was to clone the full-length cDNA of
the rabbit FcRn a-chain by using 59- and 39-RACE PCR
technology, based on available rabbit FcRn fragments. Our data
(together with another rabbit FcRn a-chain sequence in the
meanwhile deposited into GenBank, without further characteriza-
tion) shows that the rabbit FcRn a-chain amino acid sequence
shows high similarity to its orthologous (Fig. 2). One of
the hallmarks of the Fc - FcRn binding interaction is its pH
dependence; Fc has full binding activity towards FcRn at pH 6,
but minimal binding occurs at pH 7.4. Previous experimental data
showed, that gain of significant binding activity at near neutral pH
results in reduced release during exocytosis at the plasma
membrane and enhanced trafficking of the IgG into lysosomes
[56]. Structural data [33,57] and other site-directed mutational
studies [58] implicated Glu115 and Asp130 on human FcRn
(Glu117 and Glu132 in rat FcRn) as being responsible for the pH
dependent binding to residues His310 and His435 on Fc. A proton
on histidine’s imidazole side-chain can be titrated between pH 6
and 7.4 and results in an ionic molecular switch for binding to
FcRn. We found that the key residues that are involved in the
FcRn - IgG interaction are highly conserved in rabbit, suggesting
that the binding occurs at pH 6.0, like in other species. To confirm
this hypothesis, we analyzed this interaction in a pH dependent
IgG-binding assay that was described earlier [50]. We have used
yolk sac lysates of 24 dpc fetuses and analyzed its pH dependent
binding at pH 6.0 and pH 7.4 to rabbit IgG that was coupled to a
Sepharose matrix. Absorbed proteins were then eluated from the
matrixandthepresenceofthe FcRn wasWesternblottested inthese
samples as well as in the unbound fractions. Fig. 6 shows that the
eluted samples contain FcRn only if binding occurred at pH 6.0, but
not at pH 7.4, indicating that, similar to all of its orthologous
analyzed so far, the rabbit FcRn interacts with rabbit IgG at pH 6.0,
but not at pH 7.4. The strict pH dependent interaction of IgG and
therabbitFcreceptorexpressedintherabbityolksacwasquestioned
by Meads and Wild [49]. In their study, they used a similar pH
dependent binding assay in which pH dependent interaction of
matrix linked rabbit IgG and soluble protein extract from yolk sac
endoderm cells of 26 dpc fetuses was tested. After binding, they
fractionated the eluted samples by SDS-PAGE; however, they could
not detect specific band when binding occurred at pH 6.0 followed
by elution at pH 8.0, using silver-staining. We believe that the FcRn
specific antibody we used (in a more specific Western blot) made the
FcRn specific detection possible in our system.
It has been well established that rabbit placenta is not
permeable to maternal IgG and that the transfer of this antibody
(and a lower extent albumin) occurs across the rabbit fetal yolk sac
membrane (YSM) from the maternal uterine lumen to the
fetus [47]. Because we have successfully detected rabbit FcRn
expression in rabbit fetuses (Fig. 1 and Fig. 4), and also in yolk
sac lysates (while studying the pH dependent rabbit FcRn IgG
interaction; Fig. 6), we then analyzed the cellular distribution of
this receptor in the rabbit yolk sac membrane, amnion and
placenta from 23 dpc fetuses. We have selected this time point
from previous data which indicated that the rate of transmission of
rabbit IgG injected into the uterine cavity increases nearly linearly
from a low level at 20 dpc to a maximum at 26 dpc and declines
thereafter [47]. We detected strong FcRn staining in the apical
plasma membrane of the brush border’s endodermal cells, in the
apical region and in vesicles that transverse the endoderm cells of
the rabbit YSM with both FcRn specific antibodies, but there was
no staining in the placental trophoblast cells or in the amnion
(Fig. 5). Our immunohistochemistry data show a very similar
pattern to those previous studies (when absorbed IgG was detected
in these tissues [21,48,49]), suggesting that we detected rabbit
FcRn in the YSM, which is responsible for the maternal IgG
transport.
Figure 8. Reduced IgG catabolism in Tg rabbits that carry two extra copies of the rabbit FcRn. We have analyzed the half-life of rabbit IgG
in Tg (homozygous; +/+) and wt rabbits from days 2–13 after injecting OVA-specific rabbit IgG i.v. into these animals. A–B. Our analysis showed that
the Tg rabbits have increased serum persistence of rabbit IgG as the beta phase half-lives of the IgG were 7.160.5 days (mean 6 SEM) as compared
to their controls which showed 5.360.3 days. C. This difference may be even greater as non-immunized Tg rabbits have higher total IgG levels as
compared to their controls. Values shown are the mean 6 SEM. (*, P,0.05). The experiment was repeated two times with similar results.
doi:10.1371/journal.pone.0028869.g008
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e28869Figure 9. Augmented humoral immune response in transgenic rabbits. A–B.T g +/2 and wt rabbits (4 and 8 animals, respectively) were
immunized with OVA. After the booster immunization the OVA-specific IgG titers were nearly double in Tg rabbits as compared with the wt animals.
We found that the total IgG levels rose steadily after immunization and reached peak levels on day 49 in Tg and wt animals. C–D.T g +/2 and wt
rabbits (5 and 5, respectively) were immunized with TNP-BSA. The mean TNP-specific IgG level was higher in Tg rabbits as compared to their wt
controls at the peak of the immune response, on day 49, one week after the second booster immunization with an almost doubled level of total IgG
as compared to their wt controls. E–F. The same rabbits which had been immunized with TNP-BSA, were immunized with a conserved influenza
hemagglutinin epitope (HA2) conjugated to KLH. The mean of the HA2-specific IgG levels was double at the peak of the immune response, on day 56,
two weeks after the second booster immunization, with an almost doubled level of total IgG as compared to their wt controls. Values shown are the
means 6 SEM. (*, P,0.05; **, P,0.01; ***, P,0.001.).
doi:10.1371/journal.pone.0028869.g009
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analyzed the IgG transport in an in vitro culture system using
rabbit visceral yolk sac and found that monensin did not prevent
selective transcytosis of human IgG, suggesting that an acidic
compartment may not be needed for transcytosis [49]. To further
clarify the role of FcRn in the maternal IgG transport, we are
currently analyzing if there is a more efficient maternal IgG
transport in our Tg rabbits that overexpress FcRn. It is worth to
mention, that maternal IgG transport in rabbits has recently
gained a new wave of interest for its usefulness for analyzing the
effect of therapeutic monoclonal antibodies or Fc-fusion proteins
on embryofetal development [59,60].
Having characterized the rabbit FcRn, we were particularly
interested in generating Tg rabbits that overexpress FcRn and
study their IgG protection as well as humoral immune response.
We have used BAC transgenesis and created several Tg rabbit
lines that carried the integrated BAC clone and the rabbit
FCGRT gene that encodes the rabbit FcRn. After initial
characterization, line #78, which carries one extra copy when
hemizygous or two extra copies when homozygous (Fig. 7A), was
selected for further analysis. FcRn is known to be expressed in
bone marrow derived cells [10], and thus we used peripheral blood
leucocytes to analyze the expressional level of the rabbit FcRn in
these animals. Our quantitative PCR analysis showed overexpres-
sion of this receptor in hemizygous and homozygous Tg animals
compared to wt controls (Fig. 7B). This result was similar to our
Tg mice that overexpress bovine FcRn and were also created by
BAC transgenesis [27].
We then analyzed the IgG clearance in these Tg rabbits and
found that transgenic animals that overexpress rabbit FcRn
protected more efficiently the exogenous IgG as compared to their
controls (Fig. 8). This data confirmed that the transgenic rabbit
FcRn is functional and that FcRn overexpression results in longer
IgG half-life, as we, and others, have previously shown in mice
[14,26,27]. Of greatest interest was whether better protection of
IgG in FcRn Tg rabbits results in increased levels of Ag-specific
antibodies following immunization. Using these Tg rabbits we
demonstrated that immunization with ovalbumin (OVA), TNP
haptenated protein and an influenza hemagglutinin peptide
generated higher levels of Ag-specific IgG titers and also higher
total IgG levels as compared to their controls (Fig. 9). Again, these
data showed that FcRn overexpression has similarly enhancing
effect on the humoral immune response in rabbits as we observed
in mice [29,55,61]. We are currently analyzing the number of
antigen specific B-cells, the cellular composition of the spleen and
other secondary lymphoid organs during immunization that we
demonstrated contribute in this positive effect in Tg mice that
overexpress FcRn [31].
Like mice, rabbits have a short generation time, produce large
numbers of offspring and can be raised under specific pathogen
free conditions. They have long been an important source of
polyclonal and more recently also monoclonal antibodies [62,63].
As a result, there is an increasing interest in raising human
antibodies in these animals. The inactivation of immunoglobulin
genes in pigs was reported [64,65]; however, the inactivation of
endogenous immunoglobulin genes in combination with the
addition of human immunoglobulin genes has so far only been
achieved in mice and cattle [66]. Experiments are now underway
to achieve this in rabbits [67]. The responsiveness of these animals
to any given antigen, and subsequent production of sufficient
quantities of pAbs, is a key prerequisite for the viability of these
systems for commercial use. Human IgG injected into the
maternal circulation is transported well to the rabbit fetus [47]
and its clearance is similar to rabbit IgG [3] suggesting that rabbit
FcRn binds efficiently human IgG. Thus, the FcRn overexpression
technology could make qualitative and quantitative contributions
to the efficiency of these engineered animals, too.
Materials and Methods
Ethics statement
All the treatments of animals (rabbits) in this research followed
by the guideline of the Institutional Animal Care and Ethics
Committee at Agricultural Biotechnology Center that operated in
accordance with permissions 22.1/3507/000/2008 and 22.1/
1127/003/2209 issued by the Central Agricultural Office,
Hungary or the Institutional Animal Care and Ethics Committee
at ImmunoGenes Ltd. that operated in accordance with
permission 22.1/601/000/2009 issued by the Central Agricultural
Office, Hungary.
Cloning and sequencing the full length of the rabbit
FcRn cDNA
To obtain the complete rabbit FcRn cDNA we used rapid
amplification of the cDNA ends (RACE) technique based on rabbit
specific FcRn fragments that were identified in the BLAST EST
database (EB377775.1; DN888548.1. and EB37774.1). Total RNA
was extracted by using RNAzol
TM B (Tel-Test Inc, Friendswood,
TX) from rabbit liver and spleen and then reverse transcribed with
SuperScript TM III Reverse Transcriptase (Invitrogen, UK).
59-RACE – The 59-end of the rabbit FcRn was isolated using
the 59 RACE System for Rapid Amplification of cDNA Ends
Version 2.0 Kit (Invitrogen, UK) according to the manufacturer’s
instruction. Briefly, total RNA was reverse transcribed using a
rabbit FcRn-specific oligonucleotide (GSP1: 59-AAG CCC AGG
CGT AGA AGG-39). After cDNA synthesis, unincorporated
dNTPs, primer and proteins were separated from cDNA with gel
purification. A homopolymeric tail was then added to the 39-end
of the cDNA using TdT (Terminal deoxynucleotidyl transferase)
and dCTP. This product was directly used for a PCR reaction
with another rabbit FcRn specific primer (GSP2: 59- GCT CCT
TCC ACT CCA GGT T – 39) and a deoxyinosine-containing
anchor primer (Abridged Anchor primer). This amplicon was then
further applied in a nested PCR reaction with another rabbit
FcRn specific primer (GSP3: 59- GCT TGG GGT CGA AAC
TCA T-39) and an adaptor primer to the Abridged Anchor primer
(AUAP).
39-RACE -T h e3 9-end of the rabbit FcRn was isolated using the
39 RACE protocol. Briefly, total RNA was reverse transcribed using
a (dT)17-adapter primer (59- GAC TCG AGT CGA CAT CGA
(T)17-39). The resultant cDNA was then subjected to 39RACE-PCR
amplification using the adaptor primer (59-GAC TCG AGT CGA
CAT CG-39) and a rabbit FcRn specific primer (GSP4: 59-AAC
CTT CCT GCT CAC CTC CT-39). This amplicon was then
further applied in a nested PCR reaction in which the same adaptor
primer and another rabbit FcRn specific primer (GSP5: 59- GCG
ACG AGT ACC GCT ACA G-39) was used.
Cloning and Sequencing - Based on the expected size, the
proper Taq polymerase generated fragments were cloned into the
pGEM-T Easy vector (Promega Corp., Madison, WI) and fully
sequenced. FcRn sequences were searched in DDBJ/EMBL/
GenBank databases using the BLAST program. Sequence editing,
comparisons were accomplished using GeneDoc version 2.7.000 [68].
Rabbit FcRn a-chain mRNA expression in different tissues
and cells
To evaluate tissue specific expression of FcRn, we used rabbit
FcRn specific primer pair (R1B1: 59-CTG AAC GGT GAG GAC
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amplicon. To check the integrity of the synthesized cDNA we also
amplified rabbit GAPDH in these samples (RabGAPDHf: 59-
GAG CTG AAC GGG AAA CTC AC-39 and RabGAPDHfr: 59-
CCC TGT TGC TGT AGC CAA AT-3 primer pair was
used that resulted in a 304 bp long amplicon). Rabbit cDNA
synthesized from kidney, ovary, uterus, salivary gland, lymph
node, lung, brain, liver, spleen, small intestine, placenta, amnion
and yolk sac, as well as rabbit blastocyst (3.5 and 4.5 days post
coitum; dpc), rabbit embryo (6, 9 and 13 dpc) were utilized in
PCR reaction with the primers and RedTaq (Sigma-Aldrich Co.,
St. Louis, MO, USA). We also analyzed the rabbit FcRn
expression in peritoneal macrophages, which were isolated based
on a standard protocol [69]. Briefly, 500 ml 3% Brewer thioglycol
medium was injected into the peritoneal cavity and the animal was
euthanized 4 days later followed by harvesting peritoneal exudate
cells (PEC). Purity of the macrophages has been analyzed by
FACS, in which the cells were labeled by Alexa647-labeled rat
anti-mouse CD11b (eBioscience, San Diego, CA, USA) or
Alexa647-labeled rat IgG2b (eBioscience, San Diego, CA, USA),
as isotype control, respectively.
Generation of a chicken polyclonal rabbit FcRn a-chain
specific antibody
We used a chicken polyclonal antibody that was generated
against a recombinant soluble bovine FcRn protein [46] for
Western blots and also in immunohistochemistry. In brief, 200 mg
of the recombinant protein (that lacks the transmembrane and
cytoplasmic domains of the bovine FcRn a-chain) with complete
Freund adjuvant was injected intramuscular (m. pectoralis) and
subcutan (neck) in multiple sites in chickens. Three weeks later, the
animals were boosted with 100 mg of the recombinant protein with
incomplete Freund adjuvant, and this was repeated 4 times until
high titer anti-bovine FcRn serum was raised (analyzed by ELISA
and Western blot). IgY was then purified from the egg-yolk based
on standard protocol [70].
Immunohistochemical detection of the rabbit FcRn a-
chain in rabbit yolk sac, amnion and placenta
For immunohistochemistry, 23 day old fetuses were used. Yolk
sac, amnion and placenta were collected, fixed in 4% PFA (Sigma-
Aldrich Co., St. Louis, MO, USA) and embedded in paraffin
(Sigma-Aldrich Co., St. Louis, MO, USA). Tissue samples were
sectioned (4 mm) and placed on silanized slides. After deparaffina-
tion, we used 10 mM sodium citrate buffer (pH 6.0), at 95uC for
10 min for heat-induced epitope retrieval, which was followed by
endogen peroxidase blocking (1% H2O2; Fluka Chemie AG,
Switzerland). For blocking, 2.5% bovine serum albumin (BSA,
Sigma-Aldrich Co., St. Louis, MO, USA) diluted in PBS was used.
Sections were incubated with a goat polyclonal mouse FcRn a-
chain specific antibody that cross-reacts with rat, human and
bovine FcRn (K13; Santa Cruz, USA). We also used the chicken
bovine FcRn a-chain specific antibody that we validated to be
rabbit FcRn a-chain specific to detect FcRn in rabbit yolk sac
membrane. All samples with the primary antibody were incubated
at 4uC overnight. After being rinsed with 36 1% BSA/PBS for
10 min, HRP conjugated donkey anti-goat IgG (Santa Cruz, CA,
USA) or HRP conjugated rabbit anti-chicken IgG-Fc (Biodesign
International, Saco, ME, USA) as secondary antibody was applied
for 1 h at RT. For detection, 0.25 mg/ml DAB (Sigma-Aldrich
Co., St. Louis, MO, USA) diluted in PBS at RT was used. Slides
were counterstained with Meyer’s Hematoxylin (Fluka Chemie
AG, Switzerland) and mounted with DPX mounting medium
(Fluka Chemie AG, Switzerland). Sections were examined and
photographed with an Olympus microscope (Olympus, Hamburg,
Germany).
Analysis of pH dependent binding of the rabbit FcRn to
IgG
FcRn-IgG pH dependent binding assay was performed based
on a previously described protocol [50] with some modification.
As a first step, polyclonal rabbit IgG was coupled to CNBr-
activated Sepharose 4B (Pharmacia Fine Chemicals, Uppsala,
Sweden), according to the manufacturer’s instructions. Groups
remaining active were blocked with 1 M ethanolamine, pH 8.0.
The matrix was then washed and kept in 0.1 M PBS (pH 6 or 7.4)
containing 5 mg/ml CHAPS (Sigma-Aldrich Co., St. Louis, MO,
USA).
Yolk sac samples were collected from rabbit fetuses 24 dpc and
homogenized for 5000 rpm with a Precellys 24 homogenizer
(Bertin Technologies, Montigny-le-Bretonneux, France) with
0.1 M PBS (pH 6.0 or 7.4) and 0.5% CHAPS (Sigma-Aldrich
Co., St. Louis, MO, USA). Then, tissue debris was separated by
centrifugation for 20 sec, at 13000 rpm, 4uC and the samples were
stored frozen (270uC) until use. Immediately before the IgG
binding assay, the samples were thawed and protease inhibitor
cocktail (Sigma-Aldrich Co., St. Louis, MO, USA) was added at
20 ml/ml final concentration.
100-100 ml rabbit-IgG-Sepharose 4B matrix and 300-300 ml
lysate, in pH 6 or 7.4, respectively, were mixed and incubated
overnight at 4uC. As a control, 50 mg recombinant bovine FcRn
was also used. Then the matrix was centrifuged (1000 RPM,
5 minutes, 4uC), the supernatant (unbound) was concentrated with
30.000 MW Microcon filter (Millipore, Billerica, MA, USA) and
stored frozen in reducing electrophoresis sample buffer. The
matrix was then washed three times in 0.1 M PBS (pH 6.0 or 7.4)
and 0.5% CHAPS, then the adsorbed proteins were boiled with
reducing electrophoresis sample buffer. The eluted proteins
were subjected to electrophoresis on 10% SDS-PAGE gel and
transferred to a Hybond-P PVDF membrane (Amersham Pharma-
cia Biotech, Piscataway, NJ, USA). Blots were probed with a
1:10.000 diluted chicken anti-bovine FcRn antibody according to
standard protocol. Bound bovine FcRn a-chain antibody was
detected with horseradish peroxidase-conjugated rabbit anti-
chicken IgY (Fc) (Biodesign International, Saco, ME, USA)
antibody and enhanced chemiluminescence, using ECL-Plus
chemiluminescent system (Amersham Pharmacia Biotech, Piscat-
away, NJ, USA). The recombinant bovine FcRn [46] was used as
positive control.
Selection of the BAC clone that harbors the rabbit FcRn
a-chain gene (rabbit FCGRT)
A rabbit BAC library which was constructed from white blood
cells of a New Zealand rabbit [71] was used to identify a BAC
clone that contains the rabbit FCGRT gene, with rabbit FcRn
specific PCR screening method (primers: OCU_FCGRTf: 59-
GGG ACT CCC TCC TTC TTT GT-39 and OCU_FCGRTr:
59 AGC ACT TCG AGA GCT TCC AG-39).
Generation of the transgenic (Tg) rabbit carrying extra
copies of the rabbit FCGRT
BAC clone 262E02 harboring the rabbit FCGRT gene was
purified using Qiagen Large-Construct kit (Qiagen GmbH,
Germany) and was linearized by PmeI restriction enzyme
digestion. Subsequently, the linearized DNA was run on a
pulsed-field gel and recovered from the gel by GElase digestion
Boosted Ine Response in FcRn Transgenic Rabbits
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e28869(Epicentre Biotechnologies, Madison, WI, USA) [72]. The
linearized BAC DNA was injected into pronuclei of New Zealand
White rabbit zygotes. Injected eggs were transferred into
pseudopregnant females. Genomic DNA samples of founder
rabbits were collected from ear biopsies. The founder rabbits
were genotyped by a pair of primers: 59-CGA AAC AGT CGG
GAA AAT CT-39 and 59-GGC ATC GTG TGT AAG CAG AA-
39 which are specific for the BAC backbone. Transgenic rabbit
lines were maintained by sibling mating.
Determination of the transgene copy number by real
time PCR
To determine the copy number of the BAC construct carrying
the rabbit FCGRT transgene integrated into the genome, a
quantitative PCR was carried out using primers designed to
amplify a 250 bp fragment of the BAC sequence (59-CGA AAC
AGT CGG GAA AAT CT-39 and 59-GGC ATC GTG TGT
AAG CAG AA-39). Two-fold dilutions of the purified BAC DNA
samples were spiked into 1.5 ng/ml rabbit genomic DNA (final
concentration). This created a series of standard samples such that
the ratio of BAC molecules ranged from 1 to 16 BAC copies per
diploid rabbit genome. We used these samples to generate
calibration curve with equation for estimating the copy number
from sample rabbit line #78. Amplification was analyzed using the
Power SYBR Green PCR Master Mix (Life Technologies, USA)
run on Rotorgene RG-3000.
Homozygous transgenic animals were selected using genomic
qPCR. qPCR was conducted with 40 ng DNA in a 20 ml reaction
mix using the TaqMan PCR Universal Master Mix (Applied
Biosystems, USA). Custom TaqMan chemistry assays were used
for assaying rabbit b-actin (endogenous control) and rabbit FcRn
(Life Technologies, USA and Integrated DNA Technologies,
Germany, respectively) run on Rotorgene RG-3000.
Determination of the rabbit FcRn expression by real time
PCR
To test if rabbit FcRn expression increases in Tg rabbits, we
setup a real time quantitative RT–PCR, in which RNA was
isolated from rabbit leukocytes with the RNeasy Plus Mini kit (that
includes a DNase digestion step, Qiagen GmbH, Germany) and
first strand of cDNA was synthesized using the High Capacity
cDNA Reverse Transcription Kit (Life Technologies, USA).
Quantitative PCR was performed with RotorGene RG-3000
and analyzed using DDCt method (RotorGene software, Corbett
Research, Sidney, Australia). Power SYBR Green PCR Master
Mix (Life Technologies, USA) was applied for quantitative PCR
reactions. Rabbit FcRn specific primers were 59-TTG GAT CTG
GGA AAG CCA GGT G-39 and 59-TGT TCT TCA GGT CCA
CGG TCT C-39. The expression of FcRn was normalized to
rabbit beta-actin amplified by primers 59-ATC CTG ACG CTC
AAG TAC CC-39 and 59-AGC TCG TTG TAG AAG GTG
TGG T-39.
In vivo analysis of the rabbit IgG half-life in transgenic
rabbits
Following a pre-bleed, five, age and weight matched Tg
(homozygous #78 animals that carry two extra copies of the
rabbit FcRn; Tg +/+) and wt siblings as controls, respectively,
were injected intravenously (ear vein) with a single injection of
1 mg anti-OVA rabbit IgG in 1 ml of sterile PBS, and blood
samples were collected from ear vein during the next 13 days.
OVA specific IgG levels in the serum samples were measured by
an ELISA assay (as it is described below) and expressed as OD
values. The serum concentrations of OVA specific IgGs were
presented as percent remaining in the circulation at different time
points after injection compared with day 1 values (100%). IgG
clearance data was analyzed by fitting the data of days 2–13 to the
one-compartmental model using WinNonLin professional, version
5.1 (Pharsight, Mountain View, CA).
Analyzing the humoral immune response of Tg rabbits
overexpressing rabbit FcRn
Immunization. In the first experiment, Tg (hemizygous #78
animals that carry one extra copy of the rabbit FcRn; Tg +/2)
and wild type (wt) rabbits (3 months old siblings, four and eight Tg
and wt, respectively) were intramuscularly immunized with 200 mg
OVA in Complete Freund’s Adjuvant (CFA) and challenged 21
and 42 days later with 100 mg OVA in Incomplete Freund’s
Adjuvant (IFA). In the second experiment, Tg +/2 and wild type
(wt) rabbits (3 months old siblings, five in each group) were
intramuscularly immunized with 200 mg TNP-BSA in CFA and
challenged 21 and 42 days later with 100 mg TNP-BSA in IFA.
Finally, Tg and wt rabbits (7 months old siblings, previously
immunized with TNP-BSA) were intramuscularly immunized with
a KLH conjugated polypeptide (HA2: N9-TQNAINGITN-
KVNSVIE-C9) that consists of the highly conserved amino acids
41–57 of the a-helix of the influenza hemagglutinin subunit 2,
Influenza A/California/07/09(H1N1) [29]. Animals were
immunized with 200 mg HA2 peptide-KLH conjugate (HA2-
KLH) in CFA and challenged 21 and 42 days later with 100 mgo f
the conjugate in IFA.
ELISA measurements of antigen-specific and total
immunoglobulin levels. High binding ELISA plates
(Corning Inc. NY, USA) were coated with 5 mg/ml OVA, 5 mg/
ml TNP-IgY, 5 mg/ml HA2-peptide or 1 mg/ml unlabeled goat
anti-rabbit polyclonal IgG (H+L) (Southern Biotechnology
Associates, Inc., Birmingham, AL, USA), respectively, in 0.1 M
sodium carbonate-bicarbonate buffer (pH 9.6) for 2 hours at room
temperature and then were washed with 0.1 M phosphate-
buffered saline (PBS, pH 7.2) containing 0.05% Tween-20 (PBS-
T) and blocked with PBS containing 1% BSA or PBS-T for 1 h at
room temperature. Diluted serum samples were added to the wells
and incubated for 1 h at room temperature. Each plate included
standard controls of pooled antigen-specific immune sera or
serially diluted purified rabbit IgG. After washing, bound serum
antibody was revealed by horseradish peroxidase (HRP)-labeled
goat anti-rabbit IgG (Southern Biotechnology Associates Inc.
Birmingham, AL, USA) or by HRP-labeled goat anti-rabbit IgM
(Southern Biotechnology Associates Inc. Birmingham, AL, USA).
The peroxidase-conjugated antibodies were detected using
tetramethyl-benzidine (TMB) (Sigma-Aldrich Co., St. Louis,
MO, USA) as the substrate and blank-corrected optical density
at 450 nm was measured with a Multiscan ELISA Plate Reader
(Thermo Electron Corporation, USA). Serial dilutions of each
test serum samples were applied and antigen-specific titers
were determined by GraphPad Prism version 5 for Windows
(GraphPad Software, La Jolla California USA) using the one site
binding hyperbola function of non-linear regression curve fit. IgG
titers are given as half-maximal values (inflexion point titer). For
measurement of total IgG levels standard curves were constructed
by using affinity purified rabbit IgG (Sigma-Aldrich Co., St. Louis,
MO, USA) and serum IgG concentrations were determined based
on the blank-corrected absorbance values at 450 nm interpolated
from the linear portion of the standard curve. Samples were
assayed in duplicates for titer and in triplicates for total IgG
measurements.
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Statistical differences were assessed by pairwise comparisons of
relevant groups using permutation tests. Briefly, values from the
groups to be compared were randomly reassigned to two groups
and the difference between the group means was calculated.
Distribution of 5000 randomizations was drawn and the two-tailed
P-value corresponding to the real sample assignments was
determined. The arithmetic mean of 50 such P-values was
accepted as the probability of a-error. Values of P,0.05 were
considered significant and were indicated as follows: *, P-,0.05;
**, P-,0.01; ***, P-,0.001.
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